There is no association between pre-pregnancy LEEP and preterm birth or pregnancy loss before 20 weeks, according to a 7-year multicenter cohort study presented at the Society for Maternal and Fetal Medicine's Annual Meeting. The study, by George A. Macones, MD, contradicts earlier findings.
There is no association between pre-pregnancy LEEP and preterm birth or pregnancy loss before 20 weeks, according to a 7-year multicenter cohort study.
The study, by George A. Macones, MD, and colleagues from Washington University in St. Louis, contradicts earlier findings that suggested women who had undergone LEEP were at increased risk for preterm birth.
Macones said that prior research overestimated the association, and that there were “unmeasured confounding variables between women who’ve never had an abnormal Pap and those who have had LEEP.”
The study compared pregnancy outcomes of women with prior LEEP to two control groups: women with a prior history of normal Pap smears and women with a prior cervical punch biopsy. Subjects were identified through a review of pathology records at nine hospitals, including both community and tertiary hospitals, and records for all procedures were obtained. Trained research nurses conducted closed-ended phone interviews to obtain historical and medical data that was not available in charts.
In the LEEP group (n=625), 7.3% delivered prior to 34 weeks, compared with 7.7% of women in the cervical punch biopsy group (n=602), and 5.5% in the normal Pap group (n=616).
Women with prior LEEP were more likely to be older, African-American, and have diabetes.
Macones emphasized that the variety of hospital types and multiple control groups resulted in highly generalizable results.
A history including LEEP “should not influence pre-obstetrical care,” he concluded, and these patients “do not require increased surveillance or intervention for the prevention of preterm birth or early pregnancy loss.”
Read our complete coverage of the Society of Maternal and Fetal Medicine's 32nd Annual Meeting, including:
SMFM: Progesterone Does Not Prolong Pregnancy After Successful Tocolytic Treatment
SMFM: Induction of Labor Reduces Trauma Risk for Large-for-Date Fetuses
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Unveiling the complexities of preterm birth risk from nativity, ethnicity, and race
March 22nd 2024A recent study dissected the relationships between maternal nativity, ethnicity, and race in influencing preterm birth rates, shedding light on disparities and suggesting avenues for future research.
Read More
Study reveals link between opioid dosage and spontaneous preterm birth risk
February 21st 2024Recent research highlighted an association between the total dose of prescribed opioids during pregnancy and the heightened risk of spontaneous preterm birth, emphasizing the need for judicious opioid use in pain management for expectant mothers.
Read More